Long-Term Prospective Observational Study of the Risk of Cancer Among Pantoprazole Users
All subjects who met the inclusion criteria were included in the study.
- Patients who have used pantoprazole or other proton pump inhibitors, enrollment in
the health maintenance organization for at least 6 months, age 18 years or older.
- Use of any proton pump inhibitor before study entry, any cancer diagnosis recorded in
the medical history, diagnosis of Zollinger-Ellison Syndrome in medical history.
Type of Study:
Observational Model: Cohort, Time Perspective: Prospective
Risk of gastric cancer among pantoprazole users compared to users of other proton pump inhibitors during the follow-up period
Outcome Time Frame:
Up to 10 years
Pfizer CT.gov Call Center
United States: Food and Drug Administration
- proton pump inhibitor
- gastric cancer
- digestive system cancer